INTRODUCTION
on-column DNase digestion with the RNase-Free DNase Set (Qiagen Hilden, Germany). 134 Protocols were followed according to the manufacturer's instructions. Extracted RNA samples 135 were stored at -80 °C until use. Upon assay, RNA integrity was verified by agarose gel 136 electrophoresis. RNA quality and concentration were measured using an Agilent 2100 137 Bioanalyzer (Life Technologies, Carlsbad, CA). RNA (100 ng) was hybridized with a 138 predesigned nCounter human immunology panel including 594 target genes and 15 internal 139 reference genes. The geNorm algorithm was used to select the most stable of these reference 140 genes (GAPDH, PPIA, G6PD, EEF1G, GUSB, HPRT1, SDHA, RPL19) for normalization 26 . 141 The experimental procedures were carried out on the NanoString preparation station and digital 142 analyzer according to manufacturer's instructions. Two biological replicates were selected from 143 each of the four groups for analysis. 
RESULTS

169
TRAIL sensitizes Calu-3 cells to ricin toxin-induced death. Ricin is a promiscuous toxin 170 capable of killing virtually all mammalian cell types. In most cases, >50% cell death occurs 171 within 12-48 h of cells being exposed to nanogram amounts of ricin 27 . We chose Calu-3 cells as 172 a model to understand the response of human airway epithelial cells to ricin toxin. Calu-3 cells 173 are a small cell lung adenocarcinoma line widely accepted as a model to study drug and 174 nanomaterial interactions with pulmonary epithelium 28-32 . Calu-3 cells have also been used as a 175 model to assess the effects of other biothreat agents, namely botulinum toxin, on cells of the 176 human airway 33 .
177
To assess the sensitivity of Calu-3 cells to ricin toxin, confluent Calu-3 cells grown in 178 microtiter plates were treated with a range of ricin toxin doses (>1-10 µg/ml) and then assessed 179 for viability 72 h later. We found that Calu-3 cells were largely impervious to the effects of ricin 180 to the point that we were unable to establish an IC 50 value (Figure S1) . Calu-3 cell monolayers 181 grown on Transwell filters were similarly insensitive to ricin toxin ( Figure S2) . 182 We reasoned that pro-inflammatory cytokines like TNF-α, which is known to be released by 183 alveolar macrophages in response to ricin, might sensitize Calu-3 cells to toxin-induced cell 184 death 8 . TRAIL (Apo2L; CD253) is another pro-inflammatory cytokine of interest, considering 185 its role in accelerating lung epithelial cell death under conditions of ARDS 34, 35 . We examined 186 the viability of Calu-3 cells following treatment with a fixed amount of ricin (1 µg/ml) plus 187 doses of TNF-α or TRAIL ranging from 0.01 ng/ml to 1000 ng/ml (Figure 1A) . Calu-3 cells is in contrast to TRAIL, which displayed a dose-dependent enhancement of ricin-induced Calu-3 192 cell death. TRAIL was significantly more potent than TNF-α in that virtually 100% cell killing 193 was observed with >100 ng/ml TRAIL. To better define the degree of synergy between ricin and 194 8 TRAIL, we performed checkerboard analysis across a range of ricin (0-1µg/ml) and TRAIL (0-195 1µg/ml) concentrations ( Figure 1B) . This analysis identified the minimal doses ricin (250 ng/ml) 196 and TRAIL (100 ng/ml) required to achieve ~100% cell death within a 72 h period. Figure S3 ). 205 It is reported that in macrophage and epithelial cells, ricin triggers the intrinsic apoptotic 206 pathway through a process dependent on caspase-3/7 activation 13 . We therefore examined 207 caspase-3/7 activity in Calu-3 cells following treatment with ricin (250 ng/ml), TRAIL (100 208 ng/ml), or the combination of ricin and TRAIL. At the concentrations employed, neither ricin 209 nor TRAIL alone was sufficient to induce caspase-3/7 activity in Calu-3 cells ( Figure 3A) . 210 However, the combination of ricin and TRAIL resulted in a significant increase (~4-fold) in 211 caspase-3/7 activity, which was inhibited by Z-DVEVD (Figure 3A,B) . In a Calu-3 cell 212 viability assay, ZVAD (pan-caspase inhibitor), ZIETD (caspase-8 inhibitor) and ZDEVD 213 (caspase-3/7 inhibitor) were each able to partially suppress the cytotoxic effects of ricin and 214 TRAIL, but only at early time points (Figure 4) . Blocking the initiator caspase 9 with the 215 inhibitor LEHD had no effect on Calu-3 cell viability following ricin and TRAIL (Figure S4) , 216 nor did treatment with the necrosis inhibitors NSA, GSK, or Nec-1 ( Figure S4) . Collectively, 217 these results are consistent with ricin and TRAIL treatment activating apoptosis through caspase-218 8 and caspase 3/7-dependent pathways.
219
Transcriptional profiling of Calu-3 cells following ricin and TRAIL treatment. To better 220 understand the interaction between ricin and TRAIL, we subjected Calu-3 cells to transcriptional 221 profiling using a human immunology nCounter array encompassing ~600 genes target genes.
222
RNA was isolated from Calu-3 cells treated with ricin (250 ng/ml), TRAIL (100 ng/ml) or the immunology array when we compared ricin, TRAIL or ricin + TRAIL treatments to medium 226 control samples (data not shown). By 18 h, the picture was markedly different. Analysis of the 227 RNA from Calu-3 cells treated with the combination of ricin and TRAIL indicated that there 228 were ~80 genes whose expression was elevated >2 fold over the untreated controls, which 229 corresponds to roughly 12% of all the genes on the human immunology nCounter array (Figure 230 5; Table S1; Figure S5 ). Most notable was an increase in IL-6 (~750 fold), followed by other 231 pro-inflammatory cytokines like IFN-β (~120-fold), TNF-α (~120-fold), IL-8 (88-fold) IL-1α 232 (60-fold), CCL20 (90-fold). Virtually the same transcriptional profile was observed when Calu-3 233 cells were treated with just ricin, although the magnitude of the response was dampened as 234 compared to ricin + TRAIL (Figure 5; Table S1 ; Figure S5 ). TRAIL treatment alone did not 235 significantly alter Calu-3 gene expression. These results are consistent with TRAIL enhancing 236 the pro-inflammatory and apoptotic responses of Calu-3 to ricin, rather than inducing parallel or 237 convergent pro-inflammatory and apoptotic pathways.
238
To validate the transcriptional profiling studies, Calu-3 cells were treated for 24 h with ricin, 239 TRAIL or the ricin + TRAIL combination, after which culture supernatants were assayed for the 240 pro-inflammatory cytokines IL-6, IL-8, IL-1, IL-10, TNF-, and IL-12 levels by CBA. We found 241 that IL-8, IL-1, IL-10, TNF-α, and IL-12 levels were unchanged, irrespective of whether Calu-3 242 cells were treated with ricin, TRAIL, or the ricin + TRAIL combination (Figure 6) . 243 in contrast, were elevated >10 fold in supernatants from Calu-3 cells treated with ricin + TRAIL, 244 as compared to controls (Figure 6) . Treatment of cells with ricin alone enhanced IL-6 levels, 245 although not to a degree that was statistically significant. Thus, IL-6 expression was optimally 246 induced by ricin + TRAIL, whereas levels of IL-8, IL-1, IL-10, TNF-α, and IL-12 were 247 unchanged under these conditions even though corresponding mRNA levels were significantly 248 enhanced, according to nCounter analysis. 249 We postulated that the absence of TNF-α in the Calu-3 cells supernatants following ricin and 250 TRAIL treatments might be due to autocrine signaling such that soluble cytokine is rapidly 251 captured by TNF-α receptor, which in turn might contribute to ricin-induced cell death. To 252 examine this possibility, Calu-3 cells were treated with ricin plus TRAIL in the presence of 253 neutralizing anti-TNF-α antibody. We found that anti-TNF-α antibody treatment did not prevent 254 or even reduce Calu-3 cell killing in response to ricin plus TRAIL, whereas treatment with an 255 anti-TRAIL neutralizing antibody did rescue the cells (Figure S6) . Widespread damage to the airway epithelium is a hallmark of inhalational ricin exposure, 259 although the exact molecular events that culminate in epithelial cell destruction have not been 260 fully elucidated 2, 3, 5, 7, 24, 36 . In this report we utilized the well-characterized Calu-3 cell line as a 261 prototype to better define the response of human airway epithelial cells to ricin [28] [29] [30] [31] [32] . We found 262 that Calu-3 cells, when grown to confluence on solid or permeable substrates, were largely 263 impervious to the effects of ricin. However, co-administration of soluble TRAIL (and to a lesser 264 degree TNF-α) rendered Calu-3 cells >1,000-fold more sensitive to toxin-induced apoptosis, as and inhalational challenge, so it is plausible that these cells also serve as a source of TRAIL 279 following toxin exposure 3, 5, 9, 40 . The availability of TRAIL neutralizing antibodies and TRAIL 280 knock out mice will enable us to sort out the relative contribution of this cytokine to ricin-281 induced airway inflammation in vivo 34 .
282
The issue of how TRAIL sensitizes Calu-3 cells to ricin-induced cell death is of particular 283 interest, considering that TRAIL activates cell death through an extrinsic apoptotic pathway, 284 while ricin triggers intrinsic pathways induced as a result of the ribotoxic stress response (RSR), 285 unfolded protein response (UPR) and/or increased levels of intracellular calcium 13, 25 . We 286 postulate that caspase-3 serves as the central node through which ricin and TRAIL intersect. In 287 11 human cells, activation of TRAIL receptor 1 (TRAIL-R1) and/or receptor 2 (TRAIL-R2) 288 stimulates caspase 8 activation, which in turn triggers caspase-3 41 . Ricin-induced programmed 289 cell death is also dependent on caspase-3 activation, although which specific upstream signaling 290 pathway(s) (e.g., RSR, UPR, ER stress) is most relevant in airway epithelial cell killing have not 291 been completely elucidated 2, 12 . As demonstrated in this study, Calu-3 cell death following with 292 ricin and TRAIL treatment coincided with an increase in caspase-3/7 activity and was partially 293 inhibited by the addition of Z-DEVD-fmk, but not impacted by LEHD, an inhibitor of caspase 9.
294
Calu-3 cell death may also be exacerbated by a concomitant decline in endogenous inhibitors of 295 apoptosis such as cFLIP, due to ricin's capacity to arrest protein synthesis, as reported in the case 296 of cells treated with Shiga toxin 42 . In fact, the protein synthesis inhibitor cycloheximide is 297 commonly used as a tool to sensitize cells to TRAIL-induced apoptosis 25, 43 . While somewhat a 298 question of semantics, we would argue that TRAIL sensitizes Calu-3 cells to ricin-induced 299 apoptosis, rather than ricin-sensitizing Calu-3 cells to TRAIL-induced cell death. This claim is 300 best supported by transcriptional profiling we performed which demonstrated that TRAIL 301 amplifies across the board the effects of ricin on the treatment of Calu-3 cells. Treatment with 302 TRAIL alone had no effect on Calu-3 gene expression, nor did TRAIL (by itself) negatively 303 influence Calu-3 cell viability. 304 We identified IL-6 as being markedly up regulated in Calu-3 cells at the transcriptional and 305 protein levels following ricin and ricin plus TRAIL treatments. This finding may have important 306 implications for understanding the pathology associated with pulmonary ricin exposure, 307 especially in non-human primates where elevated levels of IL-6 in bronchoalveolar lavage 308 (BAL) fluids are associated with negative outcomes following toxin exposure (C. Roy, Y. Rong, 309 D. Ehrbar, N. Mantis, manuscript in preparation). IL-6 also accumulates in BAL fluids and 310 serum of mice following intranasal ricin challenge (Y. Rong and N. Mantis, manuscript in 311 preparation) 9, 22, 40, 44 . Whether IL-6 is more than just a biomarker of ricin intoxication remains 312 to be determined, but there is considerable evidence to implicate this cytokine in driving local 313 and systemic pathologies 45, 46 . Surprisingly, Calu-3 cells did not secrete detectable levels of 314 other "initiator" cytokines TNF-α and IL-1, or the chemokine IL-8, even though each of their 315 respective mRNA transcripts were significantly unregulated by ricin or ricin plus TRAIL. Wong 316 et al noted that TNF-α secretion actually declined when primary human bronchial epithelial cells 317 were exposed to ricin, presumably due to a global arrest in protein synthesis 12 . The continued 12 (and possibly preferential) synthesis of IL-6, not TNF-α, in ricin intoxicated cells may have to do 319 with differential rates of mRNA stability, especially when mitogen-activated protein kinase 320 (MAPK) signaling pathways are activated 47 . It is worth noting that Wong and colleagues 321 reported that in primary human bronchial epithelial cells TNF-α and IL-1β expression in 322 response to ricin is dependent on NfκB, but IL-6 is not 12 . 462 after cells exposed to ricin (0.25µg/ml) and TRAIL (0.1µg/ml). All treatments were performed in 463 triplicate and repeated for 3 times. 100% viability was defined as the average value obtained 464 from wells in which cells were treated with medium only. 
